Immunomodulation of Experimental Autoimmune Encephalomyelitis with Ordered Peptides Based on MHC-TCR Binding Motifs
Author(s) -
Pedro Ruiz,
Jason DeVoss,
Louis-Vu T. Nguyen,
Paulo Fontoura,
David L. Hirschberg,
Dennis J. Mitchell,
K. Christopher García,
Lawrence Steinman
Publication year - 2001
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.167.5.2688
Subject(s) - experimental autoimmune encephalomyelitis , t cell receptor , myelin basic protein , multiple sclerosis , t cell , major histocompatibility complex , myelin , immunology , chemistry , mhc class ii , biology , microbiology and biotechnology , antigen , immune system , central nervous system , neuroscience
T cell-mediated destruction of the myelin sheath causes inflammatory damage of the CNS in multiple sclerosis (MS). The major T and B cell responses in MS patients who are HLA-DR2 (about two-thirds of MS patients) react to a region between residues 84 and 103 of myelin basic protein (1 ). The crystal structure of HLA-DR2 complexed with myelin basic protein(84-102) confirmed that Lys(91) is the major TCR contact site, whereas Phe(90) is a major anchor to MHC and binds the hydrophobic P4 pocket (2 ). We have tested peptides containing repetitive 4-aa sequences designed to bind critical MHC pockets and to interfere with T cell activation. One such sequence, EYYKEYYKEYYK, ameliorates experimental autoimmune encephalomyelitis in Lewis rats, an animal model of MS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom